周一,RBC Capital Markets调整了对Korro Bio Inc. (NASDAQ:KRRO)股票的展望,将目标价从95美元上调至105美元,同时维持"跑赢大市"评级。这一上调是在与公司管理层讨论后做出的,管理层在评估了行业近期发展后,对RNA编辑技术的潜力表示有信心。 Korro Bio注意到了同行在该领域的数据,这些数据打消了此前对ADAR(作用于RNA的腺苷脱氨酶)在人体中药效 ...
Adar Poonawalla is acquiring a 50% stake in Karan Johar's Dharma Production and Dharmatic Entertainment for Rs 1,000 crore, valuing the company at Rs 2000 crore, according to a report. Johar ...
Billionaire businessman Adar Poonawalla’s Serene Productions will invest 10 billion rupees ($119 million) in Indian producer Karan Johar’s Dharma Productions and Dharmatic Entertainment ...